Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Amikacin in Ventilated Patients With Gram-Negative Pneumonia
NCT01004445Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of amikacin in pneumonia, sponsored by Bayer. Started May 2005; status: completed.
02
Drugs
amikacin
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT01004445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004445.